Industry NewsMinoryx Therapeutics Announces Dosing of First Patient in ADVANCE Trial, a Phase 2/3 Clinical Study of MIN-102 in Patients with Adrenomyeloneuropathy (AMN)
Editorial ArticleVote for the Best New Drug Discovery & Development Product of 2017 in the Scientists’ Choice Awards
Industry NewsAnticancer Agent Lenvatinib Designated for Priority Review and Approval by CFDA for Hepatocellular Carcinoma
Product NewsRyzodeg Shown to Significantly Reduce the Risk of Low Blood Sugar in People with Type 2 Diabetes Who Fast During Ramadan
Editorial ArticleScientists’ Choice Awards Nominations Open for Best New Drug Discovery & Development Product of 2017
Product NewsOwlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial
Industry NewsPall Partners with BioFactory Competence Center to Launch Practical Continuous Bioprocessing Courses